SR31747A: A peripheral σ ligand with potent antitumor activities

Anti-Cancer Drugs

Volumn 15, Issue 2, 2004, Pages 113-118

  Casellas, Pierre ^a   Galiegue, Sylvaine ^a   Bourrie, Bernard ^a   Ferrini, Jean Bernard ^a   Jbilo, Omar ^a   Vidal, Hubert ^a  

^a SANOFI   (France)

Author keywords

Antitumor effect; Breast cancer; Prostate cancer; SR31747A; Transcriptome; ligand

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; FLUTAMIDE; LIGAND; LIPOPOLYSACCHARIDE; N CYCLOHEXYL N ETHYL 3 (3 CHLORO 4 CYCLOHEXYLPHENYL) 2 PROPENYLAMINE; N CYCLOHEXYL N ETHYL 3 (3 CHLORO 4 CYCLOHEXYLPHENYL)PROPEN 2 YLAMINE; STAPHYLOCOCCUS ENTEROTOXIN B; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; BINDING SITE; BREAST CANCER; CELL LINE; CLINICAL TRIAL; CONCENTRATION RESPONSE; DRUG POTENCY; GRAFT REJECTION; HUMAN; IMMUNOMODULATION; LYMPHOCYTE; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS;

EID: 1542358940     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200402000-00003     Document Type: Review

References (27)

1. Paul R, Lavastre S, Floutard D, Floutard R, Canat X, Casellas P, et al. Allosteric modulation of peripheral σ binding sites by a new selective ligand: SR 31747. J Neuroimmunol 1994; 52:183-192.
2. Casellas P, Bourrie B, Canat X, Carayon P, Buisson I, Paul R, et al. Immunopharmacological profile of SR 31747: in vitro and in vivo studies on humoral and cellular responses. J Neuroimmunol 1994; 52:193-203.
3. Carayon P, Petitpretre G, Bourrie B, Le Fur G, Casellas P. In vivo effects of a new immunosuppressive σ ligand, SR 31747, on mouse thymus. Immunopharmacol Immunotoxicol 1996; 18:179-191.
4. Carayon P, Bouaboula M, Loubet JF, Bourne B, Petitpretre G, Le Fur G, et al. The σ ligand SR 31747 prevents the development of acute graft-versus-host disease in mice by blocking IFN-gamma and GM-CSF mRNA expression. Int J Immunopharmacol 1995; 17:753-761.
5. Derocq JM, Bourrie B, Segui M, Le Fur G, Casellas P. In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the σ ligand SR 31747. J Pharmacol Exp Ther 1995; 272:224-230.
6. Bourrie B, Benoit JM, Derocq JM, Esclangon M, Thomas C, Le Fur G, et al. A σ ligand, SR 31747A, potently modulates Staphylococcal enterotoxin B-induced cytokine production in mice. Immunology 1996; 88:389-393.
7. Bourrie B, Bouaboula M, Benoit JM, Derocq JM, Esclangon M, Le Fur G, et al. Enhancement of endotoxin-induced interleukin-10 production by SR 31747A, a σ ligand. Eur J Immunol 1995; 25:2882-2887.
8. Labit-Le Bouteiller C, Jamme MF, David M, Silve S, Lanau C, Dhers C, et al. Antiproliferative effects of SR31747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the sterol isomerase step. Eur J Biochem 1998; 256:342-349.
9. Berthois Y, Bourrie B, Galiegue S, Vidal H, Carayon P, Martin PM, et al. SR31747A is a σ receptor ligand exhibiting antitumoural activity both in vitro and in vivo. Br J Cancer 2003; 88:438-446.
10. Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W, Bowen WD. Rat liver and kidney contain high densities of σ and σ receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol 1994; 268:9-18.
11. Jbilo O, Vidal H, Paul R, De Nys N, Bensaid M, Silve S, et al. Purification and characterization of the human SR 31747A binding protein. A nuclear membrane protein related to yeast sterol isomerase. J Biol Chem 1997; 272:27107-27115.
12. Kekuda R, Prasad PD, Fei YJ, Leibach FH, Ganapathy V. Cloning and functional expression of the human type σ receptor (hSigmaR1). Biochem Biophys Res Commun 1996; 229:553-558.
13. Silve S, Dupuy PH, Labit-Lebouteiller C, Kaghad M, Chalon P, Rahier A, et al. Emopamil binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits delta8-delta7 sterol isomerase activity in yeast. J Biol Chem 1996; 271:22434-22440.
14. Dussossoy D, Carayon P, Belugou S, Feraut D, Bord A, Goubet C, et al. Colocalization of sterol isomerase and σ(1) receptor at endoplasmic reticulum and nuclear envelope level. Eur J Biochem 1999; 263:377-386.
15. 2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. J Biol Chem 1995; 270:7551-7557.
16. Paul R, Silve S, De Nys N, Dupuy PH, Bouteiller CL, Rosenfeld J, et al. Both the immunosuppressant SR31747 and the antiestrogen tamoxifen bind to an emopamil-insensitive site of mammalian delta8-delta7 sterol isomerase. J Pharmacol Exp Ther 1998; 285:1296-302.
17. Vidal H, Mondesert G, Galiegue S, Carriere D, Dupuy PH, Carayon P, et al. Identification and pharmacological characterization of SRBP-2: a novel SR31747A binding protein. Cancer Res 2003; 63:4809-4818.
18. Moebius FF, Fitzky BU, Wietzorrek G, Haidekker A, Eder A, Glossmann H. Cloning of an emopamil binding protein (EBP)-like protein that lacks sterol delta8-delta7 isomerase activity. Biochem J 2003; 374:229-237.
19. Moebius FF, Striessnig J, Glossmann H. The mysteries of σ receptors: new family members reveal a role in cholesterol synthesis. Trends Pharmacol Sci 1997; 18:67-70.
20. Wolfe SA Jr, Culp SG, De Souza EB. Sigma-receptors in endocrine organs: identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary. Endocrinology 1989; 124:1160-1172.
21. De Souza EB, Kulsakdinum C, Wolfe SA, Battaglia G, Jaffe JH. Sigma receptors in human peripheral blood leukocytes and rat spleen identification and characterization. Neurosci Branch Nida Addition Res Baltimore 1987; 46:1128.
22. Vilner BJ, John CS, Bowen WD. Sigma-1 and σ-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res 1995; 55:408-413.
23. Simony-Lafontaine J, Esslimani M, Bribes E, Gourgou S, Lequeux N, Lavail R, et al. Immunocytochemical assessment of σ-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors. Br J Cancer 2000; 82:1958-1966.
24. Mach RH, Smith CR, al Nabulsi I, Whirrett BR, Childers SR, Wheeler KT. Sigma receptors as potential biomarkers of proliferation in breast cancer. Cancer Res 1997; 57:156-161.
25. Wheeler KT, Wang LM, Wallen CA, Childers SR, Cline JM, Keng PC, et al. Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br J Cancer 2000; 82:1223-1232.
26. Cinato E, Peleraux A, Silve S, Galiegue S, Dhers C, Picard C, et al. A DNA microarray-based approach to elucidate the effects of the immunosuppressant SR31747A on gene expression in Saccharomyces cerevisiae. Gene Expr 2002; 10:213-230.
27. Ferrini JB, Jbilo O, Peleraux A, Combes T, Vidal H, Galiegue S, et al. Transcriptomic classification of antitumor molecules: application for molecular analysis of the antitumoral effect of SR31747A. Gene Expr 2003; in press.